Nobivac Lyme (25 Doses) | On Sale | EntirelyPets Rx
EPRX Logo
Licensed U.S. Pet Pharmacy | Verified Pharmacy
Mobile Menu
Search Submit
Live Chat My Account
View Cart 0

Sitewide Sale!  15% OFF  Use Code EPX15 *

  • Product ImageProduct Image

Nobivac Lyme (25 Doses)

Item# 236725
FREE SHIPPING Over $79! * Pet Food & Other Exclusions
QTY:-+

Price too low to show

Add to cart to see low price
$349.00$453.99
Recurring Saings in EprxAUTOSHIP & SAVE[Details]
Recurring Saings in EprxAUTOSHIP & SAVE[Details]
  • Notice
  • Description
  • Directions
  • Reviews

Notices

Shipping is $36.95 + a $6 surcharge for ice. Your order will ship via Express 1-2 day mail and will be packed in an insulated box with ice packs. Items that are required to ship this method will be listed in the item description. Orders placed after 2:00 PM EST (11:pp AM PST) may not end up being able to ship out the same day.

Restrictions: All foreign orders are ineligible. Free shipping is ineligible.

Note: Vaccine orders are only shipped out on Mon-Wed. due to Express service only being able to deliver during weekdays. We cannot be responsible for vaccine or other refrigerated orders that are delayed because no one is present at the time it is delivered.

Description

Nobivac Lyme the first vaccine licensed to aid in the prevention of subclinical arthritis and other signs of Lyme disease. The vaccine contains a traditional isolate targeted at OspA and a unique isolate proven to induce high levels of Borreliacideal antibodies to OspC1,2

  • Lyme vaccine designed to target the 2 key outer surface proteins (Osps) involved in disease transmission for a full level of protection.
  • Proven to induce borreliacidal antibodies that bind to OspA and OspC, forming a complex that attacks the cell membrane and kills Borrelia burgdorferi. 1,2
  • Proven to help prevent clinical disease such as arthritis.2
  • Highly effective: no serologic evidence of exposure to Borrelia burgdorferi.2
  • Nobivac is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

    Directions

  • Subcutaneous injection
  • Two 1-mL doses given 2 to 4 weeks apart
  • The last dose may be given at 12 weeks of age
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1-mL dose
  • Customers Who Bought Also Bought